Clinical trial Recruiting at 8 sites Observational Ages 18 and up

AI-based assessment of heart function using ECG wearable monitors

Official title: AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Using COR ECG Wearable Monitor

Run by Peerbridge Health, Inc · NCT06699056 · Data updated 2026-11-12

This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorPeerbridge Health, Inc
Industry-sponsored
Locations8 sites (Orange, California and 7 other locations)
StatusRecruiting
StartedNovember 21, 2024
Main results expectedNovember 15, 2027
Study endsNovember 15, 2027
Registry record updatedJune 1, 2026
Trial IDNCT06699056 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who can wear a Holter monitor and are not receiving mechanical or renal support.

Probably not a fit

Patients requiring mechanical respiratory or circulatory support, or those with severe skin reactions to ECG adhesives, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the accuracy of an AI software designed to assess ejection fraction (EF) severity using continuous ECG data from the Peerbridge COR® ECG Wearable Monitor. Participants will wear the device during a 15-minute resting period, and the AI's EF estimates will be compared to results from a standard echocardiogram. The goal is to provide a low-cost, accessible alternative for monitoring heart function, particularly in patients with heart failure. This approach aims to improve the accuracy and convenience of cardiac evaluations in everyday settings.

Why it matters

Potential benefit: If successful, this study could enable more accessible and accurate monitoring of heart function for patients with heart failure.

How similar studies have gone: Previous studies have shown promising results with AI-enabled ECG analysis for estimating ejection fraction, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Able and eligible to wear a Holter monitor

Exclusion Criteria:

* Receiving mechanical respiratory or circulatory support, or renal support therapy, at the time of screening or during Visit #1
* Any condition that, in the investigator's opinion, could interfere with compliance with the study protocol or pose a safety risk to the participant
* History of poor tolerance or severe skin reactions to ECG adhesive materials

Where it's running

  • Orange County Heart Institute
    Orange, California, United States
    Recruiting
  • Peerbridge Health
    Pasadena, California, United States
    Recruiting
  • Henry Ford Hospital
    Detroit, Michigan, United States
    Recruiting
  • Hackensack University Medical Center
    Hackensack, New Jersey, United States
    Recruiting
  • Mount Sinai Hospital
    New York, New York, United States
    Recruiting
  • Moses H. Cone Memorial Hospital
    Greensboro, North Carolina, United States
    Recruiting
Show 2 more locations
  • Texas Cardiac Arrhythmia Research Foundation
    Austin, Texas, United States
    Recruiting
  • South Heart Clinic
    Weslaco, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.